Latest Breaking News On - பீட்டர் பச்சை இலை - Page 1 : comparemela.com

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of .

United statesUnited kingdomNeil solomonsRob huizingaGlenn schulmanPeter greenleafAurinia pharmaceuticals incExchange commission electronic document gatheringDrug administrationRiptide bioscience incThunderbolt pharma incInvestor relations corporate communicationsChief executive officerRecombinant fc protein targetingThunderbolt pharmaB cell activating factor

Aurinia stocks pipeline with $7M deal for 2 preclinical assets after securing crucial FDA nod

Aurinia stocks pipeline with $7M deal for 2 preclinical assets after securing crucial FDA nod
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United kingdomPeter greenleafEuropean medicines agencyAurinia pharmaceuticalsThunderbolt pharmaRiptide bioscienceB cell activating factorProliferation inducing ligandPresident peter greenleafOtsuka pharmaceutical europeஒன்றுபட்டது கிஂக்டம்பீட்டர் பச்சை இலைஒரினிய மருந்துகள்

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
bctechnology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bctechnology.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBrinda balakrishnanPeter greenleafCompany phaseAurinia pharmaceuticals incCompany board of directorsEuropean unionEuropean medicines agencyAurinia pharmaceuticalsOtsuka pharmaceutical co ltdCompany quarterly report on formBalakrishnan is group viceBusiness development of biomarin pharmaceutical incChief executive officerGroup vice president

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBrinda balakrishnanPeter greenleafGlenn schulmanCompany phaseAurinia pharmaceuticals incExchange commission electronic document gatheringCompany board of directorsCorporate communicationsEuropean unionEuropean medicines agencyAurinia pharmaceuticalsOtsuka pharmaceutical co ltdCompany quarterly report on formBalakrishnan is group vice

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United statesPeter greenleafGlenn schulmanDavid martinBrinda balakrishnanNeil solomonsMax colaoAlethia youngJustin kimMaurice raycroftMichael haydenEmily cantor fitzgeraldJoe millerJoseph schwartzAurinia pharmaceuticals incCanadian security authority